The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution
about
Structural determinants of growth factor binding and specificity by VEGF receptor 2Structural Insights into the Binding of Vascular Endothelial Growth Factor-B by VEGFR-1D2: RECOGNITION AND SPECIFICITYPlacental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disordersModulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.Platelet-derived growth factor (PDGF)-C, a PDGF family member with a vascular endothelial growth factor-like structure.The discovery of placenta growth factor and its biological activity.Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardiumBlockade of Vascular Endothelial Growth Factor (VEGF) Aggravates the Severity of Acute Graft-versus-host Disease (GVHD) after Experimental Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)Determinants of placental vascularity.Tying the knot: the cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines.Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease.The role of VEGF receptors in angiogenesis; complex partnershipsNovel vascular endothelial growth factor D variants with increased biological activityActivated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle.The discovery of angiogenic growth factors: the contribution of Italian scientists.Placental growth factor (PlGF): a key to optimizing fetal growth.Placental growth factor: What hematologists need to know.Genetic, metabolic and endocrine aspect of intrauterine growth restriction: an update.Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis.Structural architecture and functional evolution of WntsA set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling.The biflavonoid amentoflavone inhibits neovascularization preventing the activity of proangiogenic vascular endothelial growth factors.Pressuromodulation at the cell membrane as the basis for small molecule hormone and peptide regulation of cellular and nuclear functionInterstitial Outburst of Angiogenic Factors During Skeletal Muscle Regeneration After Acute Mechanical Trauma.Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.Placental Growth Factor in Patients with Decreased Renal FunctionPro-angiogenic therapeutics for preeclampsia
P2860
Q27659686-E87EF6C9-EFD1-4331-AD48-CBA45320EF1EQ27661923-202FA8CD-1534-451C-AC9E-4A0A0F355895Q28646428-279BFEC1-9210-40E5-9A98-146801F3D8B6Q33376945-DD6E8BCA-CDA1-4407-91E0-70AB0C08C54CQ34178982-FB864218-CA82-4F8E-9E4D-33D0A87F996BQ34245619-103E584C-C0AF-47CB-BDC3-80210CEFCCFEQ34485841-0DD299E7-44B4-4F92-B7AA-2E360B2D8B9FQ35745507-AC6E12C7-2EEF-4E67-93AC-EDFBE75E8E7DQ35814522-475B8935-95E5-4CF3-9937-F508F3D0F6A5Q35895234-1B16618B-7506-4DB1-807B-887AF2503BFCQ36275826-E5F29025-3817-4C30-B412-01F06C2BF428Q36390431-CA665272-D39E-4500-8AEF-DB2AF4F9A490Q37257420-6D199895-BB05-42D2-A19E-4C14825C39CAQ37419632-62E860EC-A2E2-4805-81B2-DCF77C0A6503Q37682319-4E273BB8-11A7-4684-BCD7-1A67BB12858DQ38075008-C7A5AE46-B124-42F2-B99F-9EAD1CB27236Q38823169-CBD3EDAB-77A3-4F22-A2A8-6AA0725C86AFQ38975741-0E9D6E26-D783-445B-9B46-0302F41D5FFCQ40485583-27AAB487-B45A-49A9-91FD-82487E8DF6ADQ41831526-F1CD6A27-4CEE-42EB-9812-ACA7157739ADQ42049137-828D50B4-7EBC-4439-9414-E2887F4032F7Q42123168-27799A1B-71E9-4FE2-8896-4E1700515D66Q42153567-1F982FA2-0B89-4A26-8F0B-FE3BEC8A6B74Q53384349-CADA9F27-2206-499B-AE6D-C5160564B525Q54482424-F6F31956-30E6-4979-AA4C-53626647D1EBQ57825192-5A175C83-F89B-4CD8-A6EB-3005391237A6Q58702997-02BA2EB2-93FE-4ABA-B4F9-6F5AF51CAB3C
P2860
The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The crystal structure of human ...... c protein, at 2.0 A resolution
@ast
The crystal structure of human ...... c protein, at 2.0 A resolution
@en
The crystal structure of human ...... c protein, at 2.0 A resolution
@nl
type
label
The crystal structure of human ...... c protein, at 2.0 A resolution
@ast
The crystal structure of human ...... c protein, at 2.0 A resolution
@en
The crystal structure of human ...... c protein, at 2.0 A resolution
@nl
prefLabel
The crystal structure of human ...... c protein, at 2.0 A resolution
@ast
The crystal structure of human ...... c protein, at 2.0 A resolution
@en
The crystal structure of human ...... c protein, at 2.0 A resolution
@nl
P2093
P2860
P50
P356
P1476
The crystal structure of human ...... c protein, at 2.0 A resolution
@en
P2093
P2860
P304
12153-12161
P356
10.1074/JBC.M008055200
P407
P577
2000-11-07T00:00:00Z